American Chemical Society
|Agreement labeling||ACS Read and Publish Agreement|
|Has the agreement been fully disclosed and published?||No|
|Agreement period||11/24/2022 – 12/31/2024|
|Consortia / Institution||b-on / FCT|
Approximate range of annual corresponding author publications
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
|Comments on cost development||Cost increase includes an upgrade to all ACS publications|
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Subscriptions partly converted to OA publishing fees|
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
|Capped agreement. Expected output in hybrid journals only partially covered.|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||No|
|OA LICENSE||CC-BY preference, exceptions allowed|
||Original research articles
All articles except ebooks, additions, corrections or editorials
What is the approximate share of access related costs of the overall agreement?
|Comments on access costs||Not possible to assess accurately|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||Yes|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|